HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
獣医学研究科  >
Japanese Journal of Veterinary Research >
Volume 48, Number 2-3 >

Cardiovascular Disease : A Historic Perspective

フルテキスト
KJ00002400306.pdf2.03 MBPDF見る/開く
この文献には次のDOIがあります:http://doi.org/10.14943/jjvr.48.2-3.147

タイトル: Cardiovascular Disease : A Historic Perspective
著者: SMITH, Donald 著作を一覧する
キーワード: cardiovascular disease
coronary artery disease
lipid
LDL
atherosclerosis
発行日: 2000年11月30日
出版者: The Graduate School of Veterinary Medicine
誌名: Japanese Journal of Veterinary Research
巻: 48
号: 2-3
開始ページ: 147
終了ページ: 166
抄録: Cardiovascular disease (CVD) is the leading cause of death and disability in the United States and in most industrialized nations. Major breakthroughs to modern day cardiovascular/lipid research have been attributed to the findings of the Framingham Heart Study and Gofman and colleagues who made associations between lipoprotein levels (LDL, VLDL and HDL) and CVD. Unfortunately, half of all CVD patients have none of the established coronary risk factors (hypertension, hypercholesterolemia, cigarette smoking, diabetes mellitus, obesity) and new strategies for identifying patients need be considered. Although there remains little disagreement regarding the necessity to lower elevated plasma cholesterol levels, there remains much controversy regarding appropriate dietary means to accomplish this goal. The National Cholesterol Education Program (1993) proposed a dietary reduction (Step I and Step II diets ) to the percent saturated fat and cholesterol consumed by at-risk patients. Many currently question about the effectiveness of these diets and an alternative diet, replacing saturated fats by monounsaturated fats (olive oil), has attracted recent attention. While diet modification is considered the foundation of primary treatment, other interventions are frequently required. Although early drug trials demonstrated that agents such as nicotinic acid, clofibrate, gemfibrozil, bile acid-binding resins generally slowed progression of atherosclerotic lesions, lowered plasma cholesterol levels and decreased mortality from CVD, the greatest advance to current drug therapy involved the discovery of the "statins"(HMG-CoA reductase inhibitors). In the current work, mechanisms for vascular dysfunction resulting in myocardial ischemia were explored and potential nutritional (dietary) and pharmacologic interventions were reviewed.
資料タイプ: bulletin
URI: http://hdl.handle.net/2115/2855
出現コレクション:Volume 48, Number 2-3

 

本サイトに関するご意見・お問い合わせは repo at lib.hokudai.ac.jp へお願いします。 - 北海道大学